Annual Revenue
$257.24 M
+$46.20 M+21.89%
December 31, 2023
Summary
- As of February 7, 2025, CHRS annual revenue is $257.24 million, with the most recent change of +$46.20 million (+21.89%) on December 31, 2023.
- During the last 3 years, CHRS annual revenue has fallen by -$218.58 million (-45.94%).
- CHRS annual revenue is now -45.94% below its all-time high of $475.82 million, reached on December 31, 2020.
Performance
CHRS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$70.77 M
+$5.79 M+8.92%
September 30, 2024
Summary
- As of February 7, 2025, CHRS quarterly revenue is $70.77 million, with the most recent change of +$5.79 million (+8.92%) on September 30, 2024.
- Over the past year, CHRS quarterly revenue has dropped by -$3.79 million (-5.09%).
- CHRS quarterly revenue is now -56.54% below its all-time high of $162.84 million, reached on September 30, 2016.
Performance
CHRS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$304.34 M
-$3.79 M-1.23%
September 30, 2024
Summary
- As of February 7, 2025, CHRS TTM revenue is $304.34 million, with the most recent change of -$3.79 million (-1.23%) on September 30, 2024.
- Over the past year, CHRS TTM revenue has increased by +$93.27 million (+44.19%).
- CHRS TTM revenue is now -37.80% below its all-time high of $489.26 million, reached on September 30, 2020.
Performance
CHRS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CHRS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.9% | -5.1% | +44.2% |
| 3 y3 years | -45.9% | +20.5% | +67.3% |
| 5 y5 years | - | +20.5% | +67.3% |
CHRS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.2% | +21.9% | -22.7% | +118.2% | -6.8% | +67.3% |
| 5 y | 5-year | -45.9% | +21.9% | -47.8% | +118.2% | -37.8% | +67.3% |
| alltime | all time | -45.9% | >+9999.0% | -56.5% | >+9999.0% | -37.8% | >+9999.0% |
Coherus BioSciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $70.77 M(+8.9%) | $304.34 M(-1.2%) |
| Jun 2024 | - | $64.98 M(-15.7%) | $308.13 M(+2.1%) |
| Mar 2024 | - | $77.06 M(-15.8%) | $301.87 M(+17.3%) |
| Dec 2023 | $257.24 M(+21.9%) | $91.52 M(+22.7%) | $257.24 M(+21.9%) |
| Sep 2023 | - | $74.57 M(+27.0%) | $211.07 M(+16.0%) |
| Jun 2023 | - | $58.72 M(+81.0%) | $181.93 M(-0.8%) |
| Mar 2023 | - | $32.44 M(-28.5%) | $183.36 M(-13.1%) |
| Dec 2022 | $211.04 M(-35.4%) | $45.35 M(-0.2%) | $211.04 M(-11.7%) |
| Sep 2022 | - | $45.42 M(-24.5%) | $239.06 M(-13.4%) |
| Jun 2022 | - | $60.15 M(+0.1%) | $276.14 M(-9.1%) |
| Mar 2022 | - | $60.12 M(-18.1%) | $303.63 M(-7.0%) |
| Dec 2021 | $326.55 M(-31.4%) | $73.37 M(-11.1%) | $326.55 M(-10.2%) |
| Sep 2021 | - | $82.50 M(-5.9%) | $363.60 M(-7.9%) |
| Jun 2021 | - | $87.64 M(+5.6%) | $394.65 M(-10.9%) |
| Mar 2021 | - | $83.03 M(-24.8%) | $442.68 M(-7.0%) |
| Dec 2020 | $475.82 M(+33.6%) | $110.42 M(-2.8%) | $475.82 M(-2.7%) |
| Sep 2020 | - | $113.55 M(-16.3%) | $489.26 M(+0.4%) |
| Jun 2020 | - | $135.67 M(+16.8%) | $487.39 M(+12.0%) |
| Mar 2020 | - | $116.18 M(-6.2%) | $435.15 M(+22.2%) |
| Dec 2019 | $356.07 M | $123.86 M(+10.9%) | $356.07 M(+53.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $111.68 M(+33.9%) | $232.22 M(+92.7%) |
| Jun 2019 | - | $83.43 M(+124.9%) | $120.53 M(+224.9%) |
| Mar 2019 | - | $37.10 M(+2559.4%) | $37.10 M(-77.5%) |
| Dec 2017 | $1.56 M(-99.2%) | - | - |
| Jun 2017 | - | $1.40 M(+766.5%) | $165.24 M(-7.1%) |
| Mar 2017 | - | $161.00 K(-80.9%) | $177.91 M(-6.4%) |
| Dec 2016 | $190.11 M(+532.8%) | $844.00 K(-99.5%) | $190.11 M(-4.7%) |
| Sep 2016 | - | $162.84 M(+1057.5%) | $199.46 M(+355.5%) |
| Jun 2016 | - | $14.07 M(+13.8%) | $43.79 M(+19.7%) |
| Mar 2016 | - | $12.36 M(+21.2%) | $36.59 M(+21.8%) |
| Dec 2015 | $30.04 M(-3.4%) | $10.20 M(+42.3%) | $30.04 M(+14.1%) |
| Sep 2015 | - | $7.17 M(+4.4%) | $26.34 M(-25.2%) |
| Jun 2015 | - | $6.87 M(+18.2%) | $35.22 M(+5.7%) |
| Mar 2015 | - | $5.81 M(-10.5%) | $33.32 M(+7.1%) |
| Dec 2014 | $31.11 M(+1030.7%) | $6.49 M(-59.6%) | $31.11 M(+20.4%) |
| Sep 2014 | - | $16.05 M(+223.3%) | $25.84 M(+150.9%) |
| Jun 2014 | - | $4.96 M(+38.1%) | $10.30 M(+93.1%) |
| Mar 2014 | - | $3.60 M(+191.9%) | $5.33 M(+206.9%) |
| Dec 2013 | $2.75 M(+44.9%) | $1.23 M(+143.5%) | $1.74 M(+243.5%) |
| Sep 2013 | - | $506.00 K | $506.00 K |
| Dec 2012 | $1.90 M | - | - |
FAQ
- What is Coherus BioSciences annual revenue?
- What is the all time high annual revenue for Coherus BioSciences?
- What is Coherus BioSciences annual revenue year-on-year change?
- What is Coherus BioSciences quarterly revenue?
- What is the all time high quarterly revenue for Coherus BioSciences?
- What is Coherus BioSciences quarterly revenue year-on-year change?
- What is Coherus BioSciences TTM revenue?
- What is the all time high TTM revenue for Coherus BioSciences?
- What is Coherus BioSciences TTM revenue year-on-year change?
What is Coherus BioSciences annual revenue?
The current annual revenue of CHRS is $257.24 M
What is the all time high annual revenue for Coherus BioSciences?
Coherus BioSciences all-time high annual revenue is $475.82 M
What is Coherus BioSciences annual revenue year-on-year change?
Over the past year, CHRS annual revenue has changed by +$46.20 M (+21.89%)
What is Coherus BioSciences quarterly revenue?
The current quarterly revenue of CHRS is $70.77 M
What is the all time high quarterly revenue for Coherus BioSciences?
Coherus BioSciences all-time high quarterly revenue is $162.84 M
What is Coherus BioSciences quarterly revenue year-on-year change?
Over the past year, CHRS quarterly revenue has changed by -$3.79 M (-5.09%)
What is Coherus BioSciences TTM revenue?
The current TTM revenue of CHRS is $304.34 M
What is the all time high TTM revenue for Coherus BioSciences?
Coherus BioSciences all-time high TTM revenue is $489.26 M
What is Coherus BioSciences TTM revenue year-on-year change?
Over the past year, CHRS TTM revenue has changed by +$93.27 M (+44.19%)